The South Africa Diabetes Devices Market is expected to witness growth from $148 Mn in 2022 to $282 Mn in 2030 with a CAGR of 8.43% for the forecasted year 2022-2030. Diabetes is a serious health issue in South Africa, and it affects 9.2% of the adult population. To meet the rising demand for diabetes devices. The market is segmented by type and by the end user. Some key players in this market include Gabler medical, MediQ SHS, Johnson & Johnson, Philipps Healthcare, Medtronic, Roche and Dexcom.
The South Africa Cardiac Surgery Instruments Market is expected to witness growth from $13 Mn in 2022 to $25 Mn in 2030 with a CAGR of 7.83% for the forecasted year 2022-2030. Increase in the prevalence of Coronary Artery Disease (CAG) in South Africa. As more patients need surgical procedures to control their conditions, this is increasing demand for cardiac surgery instruments. The market is segmented by type, application and by end user. Some key players in this market include SSEM Mthembu Medical, NuAngle Medical, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
The South Africa Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.04 Bn in 2022 to $0.95 Bn by 2030, registering a CAGR of 46.45% during the forecast period of 2022 - 2030. The market will be driven by the country's high burden of disease and advanced telecommunications infrastructure. The market is segmented by healthcare components & by healthcare applications. Some of the major players include GE Healthcare, Vantage Health Technologies & Iyeza Health.
By 2030, it is anticipated that the South Africa Liver Disease Therapeutics market will reach a value of $257 Mn from $150 Mn in 2022, growing at a CAGR of 6.9 % during 2022-2030. Liver Disease Therapeutics in South Africa is dominated by a few domestic pharmaceutical companies such as Aspen Pharmacare, Adcock Ingram, and Pharma Dynamics. The Liver Disease Therapeutics market in South Africa is segmented into different types of disease and different therapy types. Some of the major factors affecting the South Africa Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
The South African healthcare insurance market is projected to grow from $13.17 Bn in 2022 to $25.92 Bn by 2030, registering a CAGR of 8.83% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing demand for private healthcare, rising healthcare costs, regulatory reforms and technological advancements. The market is segmented by the component, provider, coverage, by health insurance plans and end-user. Some of the major players include Bonitas, Discovery Health, Momentum Health, Afrocentric Health and Bestmed Medical.
South Africa anti-aging therapeutics market is expected to witness growth from $4 Mn in 2022 to $15 Mn in 2030 with a CAGR of 17.76% for the year 2022-2030. Major market drivers for the market include rising elderly population and growing awareness about anti-aging therapeutics in South Africa. The South Africa anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Thermo Fisher Scientific, Inqaba Biotechnical Industries, and Intervene Immune are some of the key players in the market.
The South Africa Biomaterials in Healthcare Market is expected to witness growth from $1.01 Bn in 2022 to $2.98 Bn in 2030 with a CAGR of 14.43% for the forecasted year 2022-2030. The lengthy life expectancy and increase in persistent health conditions in South Africa are increasing demand for medical implants, such as dental implants, spinal implants, and joint replacements. This demand is expected to lead to a rise in the demand for the biomaterials used in medical devices. The market is segmented by type and by application. Some key players in this market include: Gabler Medical, Sinapi biomedical, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
South Africa's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $192 Mn in 2022 to $375 Mn in 2030 with a CAGR of 8.73% for the year 2022-2030. The rise in the incidence of ADHD cases in South Africa and increasing urbanization are the major growth drivers of the market. The South Africa ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Mirren, Phend Pharma, and Noven Pharmaceuticals are the key competitors in the market.
South Africa 3D Printing Medical Device Market is expected to witness growth from $19 Mn in 2022 to $70 Mn in 2030 with a CAGR of 17.53% for the forecasted year 2022-2030. South Africa 3D Printing Medical devices market is expected to grow as a result of the rising prevalence of chronic diseases, ageing populations, and rising healthcare expenditure. The market is segmented by application, by technology and by end user. Some key players in this market include: Gabler medical, MediQ SHS, Stryker, Stratasys, GE Additive and Prodways Group.
South Africa's oncology clinical trials market is projected to grow from $82.2 Mn in 2022 to $138.5 Mn by 2030, registering a CAGR of 6.73% during the forecast period of 2022-30. The market will be driven by the country’s rising cancer burden and regulatory framework for clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Roche Holding AG & Aspen Pharmacare.
The South Africa healthcare claims management market is projected to grow from $173.55 Mn in 2022 to $1010.2 Mn by 2030, registering a CAGR of 24.63% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing demand for quality healthcare, rising healthcare costs, growing use of technology and government support. The market is segmented by component, type, delivery mode and by end-user. Some of the major players include Medscheme, Discovery Health, Medikredit, AXA, Cigna and Allianz.
The South Africa home healthcare market was valued at $2.36 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.93% from 2022 to 2030 and will reach $4.34 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by component and product. Some key players in this market are Medwell SA, CareChamp, Homeleigh, and others.
By 2030, it is anticipated that the South Africa Liver Cancer Therapeutics market will reach a value of $75.7 Mn from $19 Mn in 2022, growing at a CAGR of 18.8 % during 2022-2030. The Liver Cancer Therapeutics in South Africa is dominated by a few domestic pharmaceutical companies such as Aspen Pharmacare, Adcock Ingram and AstraZeneca South Africa. The Liver Cancer Therapeutics market in South Africa is segmented into different types of cancer and different therapy type. Some of the major factors affecting the South Africa Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
The South Africa Neurology Clinical Trials market is projected to grow from $34 Mn in 2022 to $57.2 Mn by 2030, registering a CAGR of 6.73% during the forecast period of 2022 - 2030. The market will be driven by the availability of a diverse population, a large number of well-trained healthcare professionals and modern medical healthcare facilities. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Eli Lilly and Company & Biovac.
The South Africa-connected healthcare market is projected to grow from $431.34 Mn in 2022 to $3239.25 Mn by 2030, registering a CAGR of 29.63% during the forecast period of 2022 - 2030. The main factors driving the growth would be private sector investments, increasing healthcare expenditure, technological advancements and government support. The market is segmented by type, function and by application. Some of the major players include Clicks Group, Netcare, Quro Medical, Roche Diagnostics, Philips Healthcare and Medtronic.
By 2030, it is anticipated that the South Africa infectious disease therapeutics market will reach a value of $1203 Mn from $779.2 Mn in 2022, growing at a CAGR of 5.6% during 2022-2030. The Infectious Disease Therapeutics in South Africa is dominated by a few domestic pharmaceutical companies such as Biovac, Adcock Ingram and Aspen Pharmacare. The Infectious Disease Therapeutics market in South Africa is segmented into different therapeutic areas and different diseases type. The major factors affecting the South African infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, COVID-19, and the amount of healthcare funding for infectious diseases treatment in various areas of South Africa.
South Africa's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $6.5 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-2030. The market will be driven by rising demand for personalized healthcare, as well as the need to address health inequities and resource limitations. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & Envisionit Deep AI
By 2030, it is anticipated that the South Africa Nutrition and Supplements market will reach a value of $xx Bn from $2.48 Bn Mn in 2022, growing at a CAGR of xx% during 2022-2030. The nutritional supplements market in South Africa is primarily dominated by local players such as Solal Technologies Aspen Pharmacare and Adcock Ingram. The market for nutrition and supplements in South Africa is primarily driven by an inclination towards better health infrastructure, government regulations and increasing consumer awareness of health and lifestyle. The South Africa nutrition and supplements market in South Africa is segmented by Type, Product, application, and Distribution Channel.
The South Africa Neurology Devices Market size was valued at $82 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Mn in 2030. The South Africa devices market has recently been growing as a result of an aging population and an increase in the demand for better healthcare services, due to factors such as an increase in the prevalence of neurological diseases, rising disposable incomes, and a stronger emphasis on healthcare infrastructure and research, it is projected that the market will grow over the coming years. The market is segmented by product type and by the end user. Some key players in this market include Medtronic, Johnson and Johnson, Stryker, Abbott Laboratories, Smith and Nephew, B. Braun Melsungen AG, and Integra Lifesciences.
The South Africa HIV therapeutics market is expected to reach $xx Mn by 2030, up from $89.44 Mn in 2022, with a CAGR of xx% from 2022 to 2030. Local Players such as Cipla Medpro, Adcock Ingram, and Aspen Pharmacare dominate the HIV therapeutics market in South Africa. The government policies, funding, and initiatives by international organizations to manage highly prevalent HIV infections in the country propel market growth. The HIV therapeutics market in South Africa is divided into four segments: type, product, geography, end user, and distribution channel.
The South Africa Palliative care market is projected to grow from $85.02 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factors driving the growth would be an increasing burden of non-communicable diseases, an increasing elderly population, and government support. The market is segmented by service type and by the end user. Some of the major players include Nelson Mandela Children's Hospital, Umduduzi, Helderberg Hospice, and St. Luke’s Combined Hospice.
The South Africa Electronic Health Record (EHR) market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. South Africa's EHR market growth is due to the government has worked on improving the legal framework for healthcare IT systems to ensure data security and privacy. The market is segmented, by application type, and end user. The key market players are FPT, Tri Viet, Allscripts, Cerner, and others.
The South Africa Bioinformatics market is projected to grow from $99.78 Mn in 2022 to $333.93 Mn by 2030, registering a CAGR of 16.30% during the forecast period of 2022 - 2030. The main factors driving the growth would be an increase in medical tourism, a growing prevalence of periodontal diseases, advancements in technology, and an increase in research and development activity. The market is segmented by technology and by application. Some of the major players include Tuesday Innovation (ZAF), BixBio (ZAF), IBM Life Sciences, Qiagen, NEC, and Thermo Fisher Scientific.
The South Africa Digital Health market is projected to grow from $xxBn in 2022 to $xxBn by 2030, registering a CAGR xx% during the forecast period of 2022 - 2030. The market will be driven by the growing demand for improved access to healthcare services and government support for digital health. The market is segmented by solution, by deployment & by end-use. Some of the major players include Philips, GE HealthCare & Altron.
The South Africa breast cancer therapeutics market size was valued at $118 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Mn in 2030. Increasing awareness initiatives for breast cancer by the government and new drug developments for the treatment of breast cancer are driving the South Africa breast cancer therapeutics market. The market is segmented by therapy, by cancer type, and by distribution channel. Some of the major market players in the South Africa breast cancer therapeutics market are Dis-Chem Pharmacies, AstraZeneca, and Eisai.